Paper Details

  1. Home
  2. Paper Details

Newer therapies for multiple sclerosis.

Author: ColesAlasdair

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Newer immunotherapies for multiple sclerosis (fingolimod, natalizumab, dimethyl fumarate, teriflunomide, alemtuzumab) offer advantages over older therapies, but also carry greater risks. As new treatments emerge (daclizumab and ocrelizumab), physicians need to strategically manage these therapies, potentially utilizing an 'escalation' or 'induction' approach. Vigilance for signs of disease breakthrough or adverse effects is crucial for both physicians and patients during treatment.
Paper Details　
Original Abstract of the Article :
The newer immunotherapies for multiple sclerosis (fingolimod, natalizumab, dimethyl fumarate, teriflunomide, alemtuzumab) offer advantages of efficacy or tolerability over the injectable therapies of the 1990s. But they also have greater risks. As further treatments emerge (daclizumab and ocrelizuma...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604695/

データ提供：米国国立医学図書館（NLM）

Newer Therapies for Multiple Sclerosis: A Journey Through the Desert of Treatment Options

The field of multiple sclerosis (MS) treatment is a vast desert, with new therapies constantly emerging to combat this complex disease. This study delves into the landscape of newer immunotherapies, comparing their efficacy and tolerability to older injectable treatments. The authors explore the advantages and risks associated with these newer therapies, highlighting the importance of a personalized treatment strategy that considers individual patient needs.

Navigating the Shifting Sands of MS Treatment

This research provides valuable insights into the evolving landscape of MS treatment. The study emphasizes the need for a personalized approach, considering the specific characteristics of each patient and the potential risks and benefits of different therapies.

A Oasis of Hope in the Desert of MS

The emergence of newer therapies for MS offers a glimmer of hope in the desert of this debilitating disease. While these treatments offer potential for improved efficacy and tolerability, it's essential to understand the associated risks and work closely with healthcare providers to navigate the vast terrain of treatment options.

Dr. Camel's Conclusion

The study emphasizes that newer MS therapies are not a one-size-fits-all solution. Just as a camel adapts to the harsh desert environment, patients must work with their healthcare providers to find the most suitable treatment strategy, considering individual needs and potential risks. The journey through MS treatment is long and challenging, but this research provides a valuable compass to guide us toward a more hopeful future.

Date :
  1. Date Completed 2015-11-05
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

26538846

DOI: Digital Object Identifier

PMC4604695

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.